Longevity Labs Shares Promising Findings from First Open Label Pilot Study to Demonstrate Impact on Heart Rate Variability of Mode+Method(TM) HRV+ Dietary Supplement in Healthy Adults

Thursday, 22 June 2023 03:35 PM

Topic: 

Product Announcements

Longevity Labs shares promising findings from first open label pilot study to demonstrate impact on heart rate variability of Mode+Method™ HRV+ dietary supplement in healthy adults

Mode+Method™ HRV+ dietary supplement improved average heart rate variability in healthy adults in first open-label pilot study

DENVER, CO / ACCESSWIRE / June 22, 2023 / Longevity Labs Inc., a company focused on developing cutting edge compounds to increase human health and lifespan, today announced the results of phase 1 of its open-label pilot study to investigate the impacts of its Mode+Method™ HRV+ dietary supplement on remote-monitored wearable technology biomarkers.

The announced phase 1 results of its open-label pilot study included 18 healthy adults and analyzed the impacts of HRV+ on wearable biometrics including HRV, AM readiness, and sleep scores, along with the WHO-5 Wellbeing Index. No qualifications of participants were required, and the study included thirteen men and five women. Intervention included a once-daily supplementation of Mode+Method™ HRV+, which was provided to participants free of charge; otherwise, participants were not compensated for their participation. Intervention did not require any adjustment to diet or exercise. Baseline biomarkers were tracked for 45 days prior to intervention and compared to biomarkers during a 30-day intervention protocol.

Upon conclusion of phase one, 77.78% of participants responded to the intervention. Average HRV improvement during intervention was 13.24%, with individual responses up to 27.8%. Other results included a 1% average improvement to AM readiness, with individual responses up to 12%; average sleep score improvements of 2.3%, with individual responses up to 11%; and an 18.4% average improvement on WHO-5 Wellbeing Index, with individual improvements up to 88%.

"These are promising and unprecedented initial results of a nutritional intervention that may move the needle on heart rate variability," said Don Moxley, Director of Applied Sciences at Longevity Labs. "Heart rate variability has greatly increased in awareness as a health marker but is an expression of highly complex biological systems. Through this study, there is additional evidence that poor heart rate variability may, in part, be a result of nutritional deficiencies that, once corrected, may further support lifestyle changes."

A novel formulation consisting of specialized hemp extracts, omega-3 fatty acids, and targeted cofactors, Mode+Method™ HRV+ was developed based on scientific literature to fuel the body's nervous system with targeted ingredients to promote a healthy heart rate variability. Mode+Method™ HRV+ is available in allowed US states via its online store, www.modemethod.com.

About Longevity Labs Inc.

Longevity Labs, founded in 2020 in Denver, CO, is a multi-brand international startup focused on improving the aging and recovery process by way of natural solutions, largely through their flagship dietary supplement brands, spermidineLIFE® (www.spermidinelife.us), and Mode+Method™ (www.modemethod.com). Their world-renowned team of researchers continues to advance daily solutions to combat cellular aging and stress through novel, natural, food-derived interventions. To learn more, visit www.longevitylabs.io.

Press Inquiries:

Bear Buscher
[email protected]
303-590-3507

Note: While the U.S. Food and Drug Administration agrees that dietary supplements can be beneficial to human health, the U.S. Food and Drug Administration (FDA) does not have the authority to review dietary supplement products for safety and effectiveness before they are marketed. Statements about the dietary supplement Mode+Method™ HRV+ are not intended to diagnose, treat, cure, or prevent any disease.

ADULT USE ONLY: Mode+Method™ HRV+ Contains cannabinoids including trace amounts of THC. Not available for sale for persons under 21 years of age.

This product is only to be purchased where lawful. You are responsible for knowing the laws of the state where you will possess these products.

SOURCE: Longevity Labs Inc.



Related Documents: